Background {#Sec1}
==========

Ventilatory strategies employing high tidal volumes (V~T~) have been shown to induce lung injury and are associated with increased mortality in patients with Acute Respiratory Distress Syndrome (ARDS) \[[@CR1], [@CR2]\]. Although the reduction in V~T~ is well recognized as a protective approach \[[@CR3], [@CR4]\], the optimal level of positive end-expiratory pressure (PEEP) remains uncertain \[[@CR5]--[@CR7]\].

Large trials comparing high and low levels of PEEP with low V~T~ failed to show differences in mortality \[[@CR8]--[@CR10]\], although an improvement in oxygenation was generally observed in the higher PEEP groups \[[@CR9], [@CR10]\]. This improvement, however, may be transitory and/or have no impact on mortality. The potential benefits of high levels of PEEP seem to be dependent upon the severity of pulmonary injury \[[@CR6], [@CR7]\] and may reduce mortality in patients with persistent and severe hypoxemia, preventing lung collapse and further hypoxia \[[@CR6], [@CR11]\].

Although it has already been shown that recruitment maneuvers associated with PEEP titration determine improvement in lung compliance and oxygenation, and reduction in cytokines levels, these analyses were mainly done in a transversal way. In the research that made a prolonged analysis (until 40 h), there was no tomographic evaluation. A prolonged longitudinal conjoint analysis of lung aeration by computed tomography (CT) scan and cytokines is lacking \[[@CR12], [@CR13]\].

In the present study, we evaluated the effects on pulmonary function, aeration and inflammatory response of two protective ventilatory strategies with low and high levels of PEEP individually titrated and sequentially applied in patients with early-established ARDS. Our analysis focused on the effects of each ventilatory strategy regarding oxygenation, lung mechanics, pulmonary aeration and inflammation after 24 h of mechanical ventilation. Our hypothesis is that individually titrated PEEP levels add benefits to protective ventilatory strategies.

Methods {#Sec2}
=======

Patient enrollment {#Sec3}
------------------

The present study was conducted at the Hospital Copa D'Or, a tertiary care hospital located in Rio de Janeiro, Brazil. The Hospital Institutional Review Board (IRB) approved the study protocol (number: HCB027/05) and written informed consent (including the permission to publish indirect identifiers) was obtained from all patients or next-of-kin relatives. Fifteen patients with clinical ARDS diagnosis \[[@CR14]\] with PaO~2~/FIO~2~ ratios lower than 300 mmHg after 30 min of mechanical ventilation with a PEEP of 5 cmH~2~O, an FIO~2~ of 1.0 and a V~T~ ranging from 8 to 10 mL/kg of ideal body weight (IBW), along with hemodynamically stable parameters (mean arterial pressures higher than 65 mmHg and arterial lactates lower than 3 mmoL/L) over the preceding 6 h \[[@CR15]\], were enrolled in the study.

Patients were excluded if more than 48 h had elapsed since their diagnosis of ARDS, or if any of the following clinical conditions were identified: pneumothorax, pneumomediastinum, bronchopleural fistula, subpleural blebs, increased intracranial pressure, a body weight greater than 140 kg, pregnancy, or a coexistent disease with an expected 6-month mortality risk exceeding 50 %.

Experimental protocol {#Sec4}
---------------------

Figure [1](#Fig1){ref-type="fig"} summarizes the experimental protocol. Briefly, all patients were kept sedated and lying in a supine position while being ventilated (SERVOi, MAQUET, Sweden) with the bed elevated at 30°. Baseline data, including ventilatory variables and arterial blood samples for gas and cytokine analyses were obtained just after patient inclusion. Thereafter, all patients were ventilated according to the ARDSnetwork low-PEEP table \[[@CR2]\], with a V~T~ of 6 mL/kg (ranging from 4 to 8 mL/kg), and plateau pressure maintained below 30 cmH~2~O over the next 24 h. After this period, respiratory variables and arterial blood samples were collected, and patients were transported to the Radiology Department for CT-scan imaging, in SERVOi, without ventilator disconnection (ARDSnet-24 h). After 24 h of ventilation according to ARDSnet, the first nine patients with the PaO~2~/FIO~2~ ratio below 350 mmHg were ventilated according to the Open Lung Concept (OLC) for the next 24 h (ARDSnet + OLC). The next six patients, regardless of their PaO~2~/FIO~2~ ratios, served as controls and remained on the ARDSnet-low PEEP table protocol for an additional 24 h (ARDSnet-48 h). At the end of this period, arterial blood samples, respiratory variables and a new whole-lung CT-scan were acquired.Fig. 1Schematic representation of the time-line interventions used during the protocol. At baseline, samples for cytokine and arterial blood gas measurements, as well as functional data, were acquired. After the first 24 h of mechanical ventilation according to the ARDSnetwork protocol, a new set of functional measurements was performed, including a whole-lung CT-scan exam. Patients were subsequently divided into two groups (ARDSnet-48 h or ARDSnet + OLC). At the end of the protocol (a total of 48 h of observation), measurements were repeated, and a new CT-scan was acquired

Open lung concept protocol {#Sec5}
--------------------------

### Recruitment maneuver (RM) {#Sec6}

In the OLC protocol, an RM was performed in Pressure Controlled Ventilation (PCV): driving pressure of 20 cmH~2~O; inspiratory time of 3 s; inspiratory to expiratory ratio (I:E) of 1:1; FIO~2~ of 1.0 and PEEP sequentially increased to 25 and 30 cmH~2~O; two minutes per step. Thereafter, driving pressure was adjusted to keep a V~T~ of 6 mL/kg (IBW) and respiratory rate (RR) was increased to 15 bpm with I:E ratio of 1:2--1:3 \[[@CR14]\].

PEEP titration {#Sec7}
--------------

Immediately after the RM, PEEP was adjusted to 17 cmH~2~O while keeping all other parameters constant for at least 20 min \[[@CR16]\]. After this period, if the PaO~2~/FIO~2~ ratio was lower than 350 mmHg \[[@CR16]\], the last step of the RM (driving pressure of 20 cmH~2~O and PEEP of 30 cmH~2~O) was repeated. Thereafter the driving pressure was adjusted to provide a V~T~ of 6 mL/kg and the PEEP was adjusted to 19 cmH~2~O. Twenty minutes afterwards, a new blood sample was collected and if the PaO~2~/FIO~2~ ratio remained below 350 mmHg, the last step of the RM was repeated and after driving pressure adjustment PEEP was set at 21 cmH~2~O. Twenty minutes later, if the PaO~2~/FIO~2~ ratio was still lower than 350 mmHg, the PEEP associated with the highest PaO~2~/FIO~2~ ratio was selected.

During the OLC protocol, the driving pressure was continuously adjusted to keep Pplat below 30 cmH~2~O and the pH higher than 7.2, with the respiratory rate ranging from 15 to 20/min. No further RMs were performed throughout the OLC protocol.

CT acquisition and analysis {#Sec8}
---------------------------

Whole-lung helical CT-scan images were acquired during an expiratory breath-hold maneuver (6 s) at 24 and 48 h of the protocol. During CT acquisitions, patients were sedated, paralyzed and ventilated with an FIO~2~ of 1.0 according to the respective ventilatory strategy.

CT images were acquired on one of three scanners: a Light Speed QX/i, a Light Speed Pro 16, or a Light Speed VCT (GE Medical Systems, Milwaukee, WI). CT scans were obtained sequentially using the following parameters: 0.8 s (Light Speed QX/i) or 0.5 s (Light Speed Pro 16 and Light Speed VCT) axial time rotations, 1.25-mm section reconstructions, 5-mm intervals, 120 kVp, 150--250 mA (Light Speed QX/i) or mA adjustment (Light Speed Pro 16 and Light Speed VCT), and a 512 × 512 pixel matrix.

Image analyses were performed with a purpose-built routine written in MatLab (Mathworks) by one of the authors (ARC). The region of interest (ROI) was manually selected in each slice by taking the inner contour of the thorax but excluding the chest wall, mediastinum, pleural effusions and regions presenting partial volume effects. For each ROI, the total volume of hyperaerated (−1,000 to −900 Hounsfield units-HU), normally (−900 to −500 HU), poorly (−500 to −100 HU) and non-aerated (−100 to +100 HU) regions were computed and color mapped \[[@CR17]\]. Additionally, the total mass of each compartment was calculated \[[@CR16], [@CR18]\]. From the total lung volume, 3D reconstructions were created by masking the lung boundary as well as each aeration compartment.

Cytokine analysis {#Sec9}
-----------------

Arterial blood samples, collected at Baseline, 24 and 48 h during the protocol, were centrifuged and the plasma stored at −70 °C for subsequent cytokine analysis.

Interleukins 6 and 8 (IL-6 and −8) were measured using commercially available ELISA kits in accordance with the manufacturer's instructions (R&D Systems, Minneapolis, EUA).

Statistical analysis {#Sec10}
--------------------

Data are presented as median, first and third quartiles. Differences were considered significant if *P* \< 0.05. The temporal effects related to changes in aeration, ventilatory variables, and cytokine analyses in each group were compared with the Wilcoxon sign rank test for paired samples. Comparisons between groups (ARDSnet-48 h and ARDSnet + OLC) were performed with the Mann--Whitney test using the SPSS statistical package (Version 16.0, SPSS, Inc.).

Results {#Sec11}
=======

Baseline parameters are presented in Table [1](#Tab1){ref-type="table"}. The majority of the patients included had pneumonia, and none had trauma. Both groups were comparable regarding age, Apache II, SOFA, time of mechanical ventilation, respiratory system compliance and PaO~2~/FIO~2~ ratio (Table [1](#Tab1){ref-type="table"}). According to the Berlin Definition \[[@CR14]\] ARDS was classified as mild in 10 patients (6 in ARDSnet + OLC and 4 in ARDSnet-48 h), moderate in 4 (2 in each group) and severe in one patient (in ARDSnet + OLC group). Outcomes are presented in Table [2](#Tab2){ref-type="table"}.Table 1Baseline characteristics of the patientsGroupAgeGenderApache IIBasal SOFAUnderlying diseaseTime on MV at baseline (hours)Crs (mLcmH~2~O)PaO~2~/FlO~2~ARDSnet + OLC71F237Pneumonia1234217ARDSnet + OLC76M177Pneumonia1120179ARDSnet + OLC63M168Pneumonia2433250ARDSnet + OLC73M188Pneumonia2241246ARDSnet + OLC62F117Pneumonia/Acute Pancreatitis725226ARDSnet + OLC31M255Pneumonia4830220ARDSnet + OLC50F227Pneumonia758229ARDSnet + OLC79M205Pneumonia243278ARDSnet + OLC46F3211Multiple transfusions2425171Median (1QR)63 (48--75)20 (17--24)5(4--7)22 (9--24)32 (25--37)220 (175--237)ARDSnet-48 h24M178Pneumonia645201ARDSnet-48 h66M104Urinary sepsis4851278ARDSnet-48 h88F196Pneumonia2440125ARDSnet-48 h41M164Pneumonia4853279ARDSnet-48 h88M197Pneumonia1335266ARDSnet-48 h66M157Pneumonia1628144Median (1QR)66 (37--88)17 (14--19)7 (5--8)20 (11--48)43 (33--52)233 (139--278)Overal Median (1QR)63 (48--75)20 (17--24)7 (6--8)15 (8--28)32 (25--37)220 (175--237)*M* male, *F* female, *Apache*, Acute Physiology and Chronic Health Evaluation II score, *SOFA* Sequential Organ Failure Assessment, *MV* mechanical ventilation, *Crs* respiratory system compliance, *PaO* ~*2*~,/*FIO* ~*2*~ arterial pressure of oxygen/inspiratory fraction of oxygen ratio Table 2Patients outcomesGroupBarotraumaLiberation of MVICU deathHospital deathDay of deathDays of ICUDays of hospitalizationARDSNet + OLCNoYesNoNo1018ARDSNet + OLCNoYesNoNo3653ARDSNet + OLCNoNoYesYes151616ARDSNet + OLCNoYesNoNo2875ARDSNet + OLCNoYesNoNo19195ARDSNet + OLCNoYesNoNo4059ARDSNet + OLCYesNoYesYes106107107ARDSNet + OLCNoNoYesYes173131ARDSNet + OLCNoYesYesYes131414ARDSNetNoYesNoNo410ARDSNetNoYesNoNo1214ARDSNetNoNoYesYes023ARDSNetNoYesNoNo1538ARDSNetNoYesNoNo1330ARDSNetNoNoYesYes14171728 (15--38)53 (17--91)Day of death means time interval (d) between protocol completion and patient death*MV* mechanical ventilation, *ICU* intensive care unit

Gas exchange, hemodynamic and respiratory variables {#Sec12}
---------------------------------------------------

Respiratory variables are presented in Table [3](#Tab3){ref-type="table"}. A significant increase in PaCO~2~ (*P* = 0.002) and a reduction in pH (*P* = 0.017) were observed after the first 24 h of ARDSnet strategy compared with Baseline. The institution of the OLC led to a significant and sustained improvement in the PaO~2~/FIO~2~ ratio (*P* = 0.008) with increased respiratory system compliance (*P* = 0.04) compared with Baseline. No significant difference was observed in PaCO~2~ (*P* = 0.26), driving or plateau pressures (*P* = 0.17 and 0.05, respectively). No significant improvement in oxygenation was observed in the ARDSnet-48 h group. The use of vasopressors and MAP levels were comparable among groups, although a lower fluid balance was observed in the OLC group (*P* = 0.04).Table 3Respiratory variablesARDSnet + OLC (*n* = 9)ARDSnet-48 h (*n* = 6)BaselineARDSnet-24 hARDSnet + OLCBaselineARDSnet-24 hARDSnet-48 hPplat (cmH~2~O)27 (23 -- 27)22 (20 -- 26)30 (24--31)18 (15 -- 25)18 (15 -- 23)20 (17--24)PEEP (cmH~2~O)5 (5 -- 5)8 (8 -- 11)17 ^a^ ^b^ (17--19)5 (5 -- 5)10 (5 -- 11)10 (7--11)Driving Pressure (cmH~2~O)14 (12 -- 19)12 (10 -- 18)12 (5--13)13 (9 -- 18)10 (7 -- 14)11 (9.25 - 14)V~T~ (mL/kg)10 (10 -- 10)8^a^ (7 -- 8)7^a^ (6--8)10 (10 -- 10)7^a^ (6 -- 8)7^a^ (6--8)VE (L/min)9 (8 -- 11)8 (8 -- 10)7 (6--9)9 (8 -- 11)7 (6 -- 8)7 (6--8)Crs (mL/cmH~2~O)32 (25 -- 37)42 (23 -- 48)46^a^ (32--91)43 (33 -- 52)48 (33 -- 68)40 (34--53)PaO~2~/FIO~2~ (mmHg)220 (175 -- 238)195 (184 -- 246)270^a^ ^b,\ c^ (220--363)233 (139 -- 278)162 (132 -- 282)177 (100--283)SaO~2~100 (96 -- 100)98 (96 -- 98)99 (98 -- 99)100 (99 -- 100)98^a^ (94 -- 99)99^a^ (97 -- 100)PaCO~2~ (mmHg)41 (28 -- 44)44^a^ (41 -- 51)49^a^ (42--58)37 (34 -- 39)47^a^ (40 -- 55)43 (39--55)pH7.4 (7.3 -- 7.4)7.3 (7.3 -- 7.4)7.3 (7.3 - 7.4)7.3 (7.3 -- 7.5)7.3 (7.2 -- 7.4)7.4 (7.2 - 7.4)*Pplat* plateau pressure of the respiratory system, *Driving Pressure* inspiratory pressure above PEEP in Pressure Controlled Ventilation Mode*V* ~*T*~ tidal volume in mL/kg of predicted body weight, *VE* minute ventilation, *PEEP* positive end-expiratory pressure, *PaO* ~*2*~/*FIO* ~*2*~ arterial pressure of oxygen/inspiratory fraction of oxygen ratio, *Crs* respiratory system compliance, *PaCO* ~*2*~ arterial pressure of carbon dioxide, *SaO* ~*2*~ arterial blood saturation. Data is presented as median, first and third quartiles^a^Significant differences compared to Baseline^b^Significant differences compared to ARDSnet-24 h^c^Significant differences compared to ARDSnet-48 h

No hemodynamic instability was observed during recruitment. During PEEP titration, three patients did not reach a PaO~2~/FIO~2~ ratio higher than 350 mmHg, even at the highest PEEP level employed (21 cmH~2~O). The PEEP was then adjusted according to the maximal oxygenation level reached at 19 cmH~2~O in 2 cases and 17 cmH~2~O in the other case.

Quantitative and qualitative CT analysis {#Sec13}
----------------------------------------

Morphological CT-scan data are shown in Table [4](#Tab4){ref-type="table"}. A significant increase in the fraction of normally aerated areas in parallel with a decrease in collapsed regions (*P* = 0.008) was observed after 24 h with OLC compared with the first 24 h with the ARDSnet protocol. No significant changes in aeration were observed in the ARDSnet-48 h group when compared with the first 24 h with ARDSnet. Comparing the OLC group with the ARDSnet-48 h group, a higher fraction of normally aerated (*P* = 0.015), with a lower fraction of collapsed regions (*P* = 0.018), was observed. No significant difference in hyperinflated regions was observed (*P* = 0.179) among groups.Table 4Quantitative CT analysisARDSnet + OLC (*n* = 9)ARDSnet-48h (*n* = 6)ARDSnet-24hARDSnet + OLCARDSnet-24hARDSnet + OLCHyper Mass (%)0 (0--1)1 0--2)0 (0--0.5)0 (0--0.5)Norm Mass (%)20 (13--22.5)38^a^ (31--42)26.5 (15--35)25 (20--39)Poorly-aerated Mass (%)25 (18--32)25 (18--42)17 (14--21)16.5 (14--20)Non-aerated Mass (%)58 (51--60)30^a^ (23--49)58 (47--68)60.5 (43--65)Hyper Volume (%)2 (0--7)5 (1--14)0 (0--4)0 (0--2)Norm Volume (%)41 (31--47)61^a^ (53--63)52 (36--63)52.5 (41--66)Poorly aerated Volume (%)21 (15--30)14 (11--29)14 (10--16)12.5 (11--16)Non-aerated Volume (%)37 (31--41)13^a^ (11--23)33 (24--48)35 (20--44)Hyper Mass, fraction of non-air content in the hyperinflated compartment related to the total lung mass; Norm Mass, fraction of non-air content in the normally aerated compartment related to the total lung mass*Poorly*-*aerated Mass* fraction of non-air content in the poorly aerated compartment related to the total lung mass, *Non*-*aerated Mass* fraction of non-air content in the non aerated compartment related to the total lung mass. Data is presented as median, first and third quartiles^a^Significant differences compared to ARDSnet-24h

The distribution of voxels per HU in each protocol is presented in Fig. [2](#Fig2){ref-type="fig"}. The OLC (Fig. [2](#Fig2){ref-type="fig"}, upper right panel) exhibited a unimodal distribution with a peak in the normally aerated compartment, whereas the histograms of the ARDSnet group exhibited a bimodal pattern with two peaks, one in the normally-aerated and the other in the non-aerated compartment after 24 (Fig. [2](#Fig2){ref-type="fig"}, left panel) and 48 h (Fig. [2](#Fig2){ref-type="fig"}, lower right panel) of mechanical ventilation.Fig. 2Histograms of the distribution of aeration (in Hounsfield Units (HU)) in patients ventilated with the ARDSnetwork protocol during the first 24 h (left hand panel) followed by ventilation using either the OLC protocol (right hand upper panel) or the ARDSnetwork protocol (right hand lower panel) for the next 24 h. The histograms are presented as the median, first and third quartiles

Representative 3D reconstructions with the respective histograms of voxels distribution of two patients are shown in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}. A predominance of collapsed areas can be observed (coloured in black) in the dorsal regions during ARDSnet-24 h (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} upper left panels). Furthermore, the bimodal pattern persisted after 48 h of mechanical ventilation with the ARDSnet protocol (Fig. [3](#Fig3){ref-type="fig"}, right panel), whereas the OLC resulted in a shift from non to normally aerated regions (Fig. [4](#Fig4){ref-type="fig"}, right panel).Fig. 3Representative 3D reconstructions with the respective histograms of voxels distribution of a patient ventilated in ARDSnet-48 h group. A predominance of collapsed areas can be observed (coloured in black) in the dorsal regions during ARDSnet-24 h (left upper panels). The bimodal pattern persisted after 48 h of mechanical ventilation with the ARDSnet protocol (right panel) Fig. 4Representative 3D reconstructions with the respective histograms of voxels distribution of a patients ventilated in ARDSnet + OLC group. A predominance of collapsed areas can be observed (coloured in black) in the dorsal regions during ARDSnet-24 h (left upper panels), whereas the OLC resulted in a shift from non- to normally aerated regions (right panel)

Cytokine analysis {#Sec14}
-----------------

Plasma concentrations of IL-6 decreased after 24 h of mechanical ventilation with OLC compared with Baseline (*P* = 0.02) and ARDSnet 24 h (*P* = 0,005 - Fig. [5](#Fig5){ref-type="fig"}). No significant difference was observed in IL-8 plasma concentration measurements.Fig. 5Plasma concentrations of IL-6 and IL-8 during the protocol. Plasma concentrations of IL-6 decreased after 24 h of mechanical ventilation with OLC compared with both Baseline (*P* = 0.02) and 24 h of ARDSnetwork (*P* = 0,005). No significant difference was observed in IL-8 among groups

Discussion {#Sec15}
==========

The main findings of the present study were: 1) a sustained improvement in oxygenation with a reduction in non and poorly aerated areas was observed after 24 h of mechanical ventilation with the OLC; 2) no significant increase in driving or plateau pressures, hyperinflated areas or cytokine levels occurred with OLC.

The hazardous effects of ventilation with high volumes are well known \[[@CR15], [@CR19]\]. Since the ARDSnet trial \[[@CR2]\], protective ventilation with low tidal volume and limited plateau pressure has been the standard of care for patients with ALI/ARDS \[[@CR3], [@CR20]\]. Although the concept of atelectrauma is also well established, strategies for its prevention (high levels of PEEP and RMs) are still under debate \[[@CR21]\]. Some studies \[[@CR8]--[@CR10]\] failed to show a reduction in mortality with the adoption of high levels of PEEP; however, in two of these \[[@CR9], [@CR10]\], high PEEP led to a reduction in the incidence of severe hypoxemia that required rescue therapy. In this context, this study was designed to explore the pathophysiological effects of OLC in comparison with a more conservative protective ventilatory strategy, aiming to evaluate the prolonged longitudinal conjoint effects on pulmonary aeration and cytokines.

Regarding oxygenation and respiratory system mechanical properties, there was a sustained improvement in oxygenation after 24 h of ventilation with the OLC, as well as an increase in respiratory system compliance in agreement with previous results \[[@CR10]\]. The benefits of RMs and high PEEPs may depend on lung recruitability, which may be highly variable \[[@CR11]\]. It has been recently shown that higher levels of PEEP improved survival only in patients with severe ARDS \[[@CR22]\]. The majority of our patients had just mild ARDS \[[@CR14]\]. Despite this, we found a significant reduction in non and poorly aerated areas, without significant increase in hyperinflated areas, plateau and driving pressures. Thus, we believe that our favorable results are a consequence of the adoption of effective RMs. Indeed, the few clinical studies that used maximal recruitment in combination with open-lung PEEP resulted in significant and sustained improvements in oxygenation, as well as in lung mechanics \[[@CR9], [@CR10]\], and in other studies, there was even a reduction in mortality \[[@CR5], [@CR23]\]. There is a close interdependence between recruitment and PEEP effects. Without an effective RM, the actual open-lung PEEP is difficult to assess \[[@CR24], [@CR25]\].

In the current study, maximal pressure levels higher than 40 cmH~2~O were applied during the RMs, which appears to be necessary to open the more dependent areas of the lung \[[@CR16]\]. The use of a PEEP that keeps PaO~2~/FIO~2~ ratio higher than 350 mmH~2~O seems to result in less than five percent of the collapsed areas \[[@CR16]\].

In our study, RMs with high pressures were not associated with deleterious hemodynamic effects. This was associated with the inclusion of patients with early ALI/ARDS who have less stiff chest walls and higher recruitment potentials \[[@CR11], [@CR19]\].

As previously reported \[[@CR26]\], RM with high airway pressures have the potential to induce overdistension leading to an increased production of inflammatory cytokines from different cells in the alveolus and pulmonary vasculature. Nevertheless, cyclic closing and overdistension, induced by lung units with different time-constants, and ventilation with inadequate PEEP levels are also associated with higher levels of cytokines in the alveolar space and blood \[[@CR27], [@CR28]\]. In the present study, plasma cytokine concentrations were measured at baseline, 24 and 48 h after patient inclusion. Despite the use of higher and more sustained pressure inflation in our RM protocol compared to other trials, we found significantly lower plasma levels of IL-6 in the OLC group when compared with the Baseline and 24 h time points of the ARDSnet. These results are in accordance with CT analysis, where OLC was associated with reduction in non and poorly aerated areas without significant hyperinflation.

The sequential approach adopted in the OLC group suggests the possibility that the progressive fall in plasma IL-6 levels may have resulted as a consequence of an improvement in clinical status. To evaluate this possibility, we analyzed a second group, which was ventilated for 48 h in the ARDSnet protocol (ARDSnet-48 h), but we did not find significant changes in cytokine levels (Fig. [5](#Fig5){ref-type="fig"}).

The study has limitations. First, it had a small sample size as it was designed to evaluate physiological variables. Second, it was done during 48 h, so inferences regarding clinical outcomes and security cannot be made after this period. Also, as it was a 48 h study, we could not assure that spontaneous breaths were not present all the time, and if so, probably it would be present more often during ventilation with higher PEEP levels and could interfere with the results in the OLC group. It is also important to emphasize that comparisons between the final results of the two groups (ARDSnet + OLC and ARDSnet-48 h) should be done with caution as patients with worse PaO~2~/FIO~2~ ratios were allocated in the ARDSnet + OLC group, maybe supporting the differences in the results favoring this group.

In summary, our data suggest that the OLC provides an effective approach to reduce the fraction of collapsed tissue without significantly increasing the fraction of hyperinflated tissue and without increasing plasma cytokine levels. We believe that this strategy could provide a viable alternative treatment option for patients with ALI/ARDS. Further studies are warranted to confirm our results and to identify subgroups of patients that will benefit the most from this strategy.

Conclusions {#Sec16}
===========

Mechanical ventilation based on an OLC, applying an individually tailored PEEP, can induce sustained improvement in pulmonary function, with better pulmonary aeration and less hyperinflated areas, without increment in cytokines.
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